Sorry, you need to enable JavaScript to visit this website.

Diving Skin Deep: Optimizing Dermatologic Care Through a Broader Lens

At Pfizer, we believe advancing health equity begins with clear-eyed leadership and a commitment to understanding the structural and social factors that shape patient experiences. As part of our mission to create breakthroughs that change people’s lives, we are constantly speaking with patients, practitioners, and experts to learn more about the challenges they face.

The Pfizer Foundation Expands Breast Cancer Initiative to Kenya and Ethiopia with $10 Million in Grants

NEW YORK, January 8, 2026 – The Pfizer Foundation today announced a new three-year, $10 million investment through its Action & Impact: A Cancer Care Initiative to expand access to timely breast cancer diagnosis, treatment, and care. This funding will support efforts in Kenya by the Academic Model Providing Access to Healthcare (AMPATH), and in Ethiopia by Innovations in Healthcare in partnership with the Clinton Health Access Initiative (CHAI). Working with national ministries of health, the partners seek to improve breast cancer care in low-resource settings by promoting earlier diagnosis and helping address barriers that delay or prevent women from accessing treatment. With this commitment, The Pfizer Foundation’s investment in addressing breast cancer inequities now totals $25 million across five countries.

Accelerating Innovation: Pfizer’s 2025 AI Festival

In late October, Pfizer colleagues around the world gathered—virtually and in person—for our second annual AI Festival Week, reaffirming our commitment to innovation and the transformative power of artificial intelligence. This year’s festival was a vibrant showcase of how AI is accelerating progress in science and healthcare, simplifying workflows, and amplifying impact for patients everywhere, at Pfizer and beyond.

The Power of Knowing: Medley’s Edith Cooper Talks Equity in AI

Over the summer, Pfizer launched “The Power of Knowing,” a video series hosted by our Chief Digital and Technology Officer, Lidia Fonseca. The series explores how artificial intelligence (AI) is unlocking innovation that was previously out of reach via interviews with industry leaders at the forefront of these changes. Today we’re excited to share a new installment that touches on a topic that’s so important to Pfizer that the concept serves as one of our core values: equity.
Subscribe to Updates